Premium
Suboptimal response to imatinib according to 2006–2009 European LeukaemiaNet criteria: a ‘grey zone’ at 3, 6 and 12 months identifies chronic myeloid leukaemia patients who need early intervention
Author(s) -
Breccia Massimo,
Orlandi Sonia M.,
Latagliata Roberto,
Grammatico Sara,
Diverio Daniela,
Mancini Marco,
Loglisci Giuseppina,
Salaroli Adriano,
Federico Vincenzo,
Santopietro Michelina,
Alimena Giuliana
Publication year - 2011
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2010.08380.x
Subject(s) - medicine , imatinib , imatinib mesylate , oncology , myeloid leukemia
[No abstract available